Clinical Trials Directory

Trials / Completed

CompletedNCT03284528

Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
University Children's Hospital, Zurich · Academic / Other
Sex
All
Age
1 Day – 4 Days
Healthy volunteers
Not accepted

Summary

The histology of the placenta of newborn infants with perinatal asphyxia and hypoxic-ischaemic encephalopathy is analysed. There will be an evaluation if placenta could be a biomarker for neurodevelopmental outcome at 18-24 months of age.

Conditions

Interventions

TypeNameDescription
OTHERhypothermia therapynewborn infants with hypoxic-ischaemic encephalopathy are cooled for 72 hours with a target temperature of 33-34°C (whole body cooling).

Timeline

Start date
2011-01-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2017-09-15
Last updated
2017-09-21

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03284528. Inclusion in this directory is not an endorsement.